Skip to content

Adam Houghton, PhD

Vice President and Head, AbbVie Ventures

Adam currently leads AbbVie’s Venture group, having formerly led the Immunology Search and Evaluation group which was responsible for strengthening AbbVie’s externally sourced Immunology pipeline, from early-stage venture investments and strategic partnerships to late-stage clinical collaborations. Previous roles include Head of Search and Evaluation at Biogen and Senior Director, Biomedicines Global External R&D, Eli Lilly where he was responsible for the sourcing of partnerships across Neuroscience, Immunology, Musculoskeletal and Cardiovascular therapeutic areas. Prior to his business development roles he held research positions at Zeneca (now AstraZeneca) and Procter & Gamble Pharmaceuticals including Section Head, Bone and Inflammation Drug Discovery. Adam received a PhD in Cell and Molecular Biology from the University of Sheffield, performed post-doctoral research at Yale School of Medicine and received an MBA from Xavier University.